Donate
|
Resource Hub
Who we are
Our Strategy
Strategy Extension
Post-Polio World
OPV Cessation
Polio Post-Certification Strategy
Transition Planning
Our Partners
Governance
Advisory and Policy Groups
International Health Regulations Emergency Committee on international spread of poliovirus
Strategic Advisory Group of Experts on Immunization
Global Commission for the Certification of Eradication of Poliomyelitis
Independent Monitoring Board
Transition Independent Monitoring Board
About Polio
Polio this week
Wild Poliovirus count
Vaccine Derived Poliovirus count
Where We Work
Poliovirus
The Vaccines
Oral polio vaccine
Inactivated poliovirus vaccine
History of Polio
What we do
Surveillance
Supplementary Immunization
Outbreak Preparedness & Response
Containment
Routine Immunization
Gender Mainstreaming
Polio Gender Champions
Integration
Environmental Safeguarding
Research
Antivirals
Clinical Trials and Seroprevalence Surveys
Polio Research Committee
Grants and Collaborations
Donors & Financing
Financial Resource Requirements
GPEI Budget 2025
GPEI Budget 2024
GPEI Budget 2023
2020-2025 outbreak budget monitoring
Expenditure Information
Historical Contributions
News
Media Centre
Take Action
Who we are
Our Strategy
Strategy Extension
Post-Polio World
OPV Cessation
Polio Post-Certification Strategy
Transition Planning
Our Partners
Governance
Advisory and Policy Groups
International Health Regulations Emergency Committee on international spread of poliovirus
Strategic Advisory Group of Experts on Immunization
Global Commission for the Certification of Eradication of Poliomyelitis
Independent Monitoring Board
Transition Independent Monitoring Board
About Polio
Polio this week
Wild Poliovirus count
Vaccine Derived Poliovirus count
Where We Work
Poliovirus
The Vaccines
Oral polio vaccine
Inactivated poliovirus vaccine
History of Polio
What we do
Surveillance
Supplementary Immunization
Outbreak Preparedness & Response
Containment
Routine Immunization
Gender Mainstreaming
Polio Gender Champions
Integration
Environmental Safeguarding
Research
Antivirals
Clinical Trials and Seroprevalence Surveys
Polio Research Committee
Grants and Collaborations
Donors & Financing
Financial Resource Requirements
GPEI Budget 2025
GPEI Budget 2024
GPEI Budget 2023
2020-2025 outbreak budget monitoring
Expenditure Information
Historical Contributions
News
Media Centre
Take Action
Choose the resource category and filter for results
Resources for Polio Eradicators
Containment
- Global Action Plan for Poliovirus Containment (GAP)
- Containment Certification Scheme (CCS)
- Potentially Infectious Material (PIM) guidance
- Exposure guidance
GPEI Tools, Protocols and Guidelines
- Polio Post-Certification Strategy
- Outbreak preparedness and response
- Vaccines and logistics
- Surveillance
- Supplementary Immunization Activities (SIA)
- Webinars and E-Learning
- Communication for Eradication Strategies
- Strategies
Policy & Reports
Advisory Committee on Poliomyelitis Eradication
AFRO Reports
Annual Reports
Containment Advisory Group
Declarations and Resolutions
Expenditure Reports
Financial Reports
- Non-FRR Reports
GACVS sub-committee on novel OPV2 safety
Gender Mainstreaming
Global Certification Commission
Global Polio Laboratory Network Reports
IMB Reports
Polio and Climate Change
Polio Newsletter
Polio Oversight Board (POB) Documents
Polio Oversight Board (POB) Letters
Polio Oversight Board (POB) Meeting Minutes
Polio Partners Group
Polio Post-Certification Strategy
Regional Certification Commission
Reports to WHO Governing Bodies
Semi-Annual Status Reports
Technical Advisory Groups
TIMB Reports
WHO Weekly Epidemiological Record
Multimedia
Photos
Videos
Sort by
Newest First
Oldest First
Filter
Reset
Resource Hub
Poliovirus containment: guidance to minimize risk for facilities collecting, handling or storing materials potentially infectious for polioviruses, 2nd ed
Web Annex D: Form 2 – Progress reporting form on preparations for poliovirus containment and completion of Phase I of GAPIII
Surveillance to track progress towards polio eradication | 07 May 2021, vol.96, no.18 (145-156)
Web Annex B: SOP for the identification, destruction or preparation for containment of poliovirus infectious or potentially infectious materials
Web Annex C: Form 1 – Facility reporting form
Technical guidance mOPV2 vaccine management, monitoring, removal and disposal – May 2021
PPG meeting 28 April 2021
Meeting report: Co-Chairs’ Statement
|
Meeting documents: PPG Meeting Presentation
|
Meeting documents: Member States Information session – Polio Transition
|
74th World Health Assembly – 2021 | Eradication of poliomyelitis
spanish
|
russian
|
french
|
english
|
chinese
|
arabic
|
GPEI position statement: use of the novel oral polio vaccine type 2 in light of shelf-life of 12 months or less
english
|
french
|
Technical Advisory Group Meeting on Polio Eradication in Afghanistan | 17, 18 and 20 March 2021
Interim Quick Reference on Strengthening Polio Surveillance during a Poliovirus Outbreak
PERFORMANCE OF ACUTE FLACCID PARALYSIS (AFP) | 05 March 2021, vol.96, no.09 (65-68)
Polio Oversight Board | Documents 2021
Response to donor statement
|
POB Planning
|
Technical Advisory Group Meeting on Polio Eradication in Pakistan | 8, 9 and 11 February 2021
Global Advisory Committee on Vaccine Safety sub-committee on novel OPV2 safety 20 January 2021
1
…
12
13
14
15
16
…
44
